Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:53 AM UTC
| NCT Number | NCT06617325 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE3 |
| Target Enrollment | 450 participants |
| Active Locations | 61 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 20, 2026: Clinical trial NCT06617325 is currently recruiting participants. This phase3 study for systemic lupus erythematosus is actively seeking new participants at 61 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06617325 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 61 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06617325 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.